Grifols SA

OZTA

Company Profile

  • Business description

    Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

  • Contact

    Avinguda de la Generalitat, 152-158
    Parc de Negocis Can Sant Joan
    Sant Cugat del Valles
    Barcelona08174
    ESP

    T: +34 935710500

    E: [email protected]

    https://www.grifols.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

    25,247

Stocks News & Analysis

stocks

Beaten down real estate share receives legal blow

Real estate share remains cheap despite losing airport legal battle.
stocks

OpenAI joins the mega-AI lab IPO race, but timing is uncertain

The ChatGPT maker joined Anthropic in filing a confidential S-1 with the SEC, teeing up a future IPO.
stocks

What happens if Tesla and SpaceX merge?

We see a solid business case for a merger, but not without hurdles, including Tesla shareholders’ concern about SpaceX’s valuation.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,006.1029.100.32%
CAC 408,346.82146.031.78%
DAX 4024,587.34377.631.56%
Dow JONES (US)50,848.75929.971.86%
FTSE 10010,420.08116.201.13%
HKSE24,718.10468.811.93%
NASDAQ25,809.66640.162.54%
Nikkei 22566,020.041,802.772.81%
NZX 50 Index13,393.87191.711.45%
S&P 5007,394.30127.311.75%
S&P/ASX 2008,804.0030.500.35%
SSE Composite Index4,031.5144.501.12%

Market Movers